Expansion of autoreactive unresponsive CD21-/low B cells in sjögren's syndrome-associated lymphoproliferation

Arthritis and Rheumatism

Volumn 65, Issue 4, 2013, Pages 1085-1096

  Saadoun, D ^a   Terrier, B ^b   Bannock, J ^c   Vazquez, T ^b   Massad, C ^c   Kang, I ^c   Joly, F ^d   Rosenzwajg, M ^b   Sene, D ^e   Benech, P ^d   Musset, L ^e   Klatzmann, D ^b   Meffre, E ^c   Cacoub, P ^a  

^a Unit of Dermatology   (France)

^b CNRS   (France)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d Prediguard   (France)

^e PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE RECEPTOR; CD40 ANTIGEN; COMPLEMENT COMPONENT C3D RECEPTOR; IMMUNOGLOBULIN; TOLL LIKE RECEPTOR;

ADULT; ANTIGEN ANTIBODY REACTION; ARTICLE; B LYMPHOCYTE; CALCIUM MOBILIZATION; CALCIUM TRANSPORT; CELL COMPARTMENTALIZATION; CELL EXPANSION; CELL FUNCTION; CELL ISOLATION; CELL POPULATION; CELL STIMULATION; CLONAL ANERGY; CONTROLLED STUDY; CYTOPLASM; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; GENE; GENE MUTATION; GENETIC ANALYSIS; HUMAN; LYMPHOCYTE PROLIFERATION; LYMPHOPROLIFERATIVE DISEASE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SJOEGREN SYNDROME;

ADULT; AGED; B-LYMPHOCYTE SUBSETS; CALCIUM; CASE-CONTROL STUDIES; CLONAL ANERGY; CRYOGLOBULINEMIA; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION PROFILING; HUMANS; LYMPHOMA, B-CELL; LYMPHOPROLIFERATIVE DISORDERS; MALE; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RECEPTORS, COMPLEMENT 3D; RNA, MESSENGER; SJOGREN'S SYNDROME;

EID: 84875752691     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.37828     Document Type: Article

References (40)

1. Groom J, Kalled SL, Cutler AH, Olson C, Woodcock SA, Schneider P, et al. Association of BAFF/BLyS overexpression and altered B cell differentiation with Sjögren's syndrome. J Clin Invest 2002; 109: 59-68.
2. Varin MM, Le Pottier L, Youinou P, Saulep D, Mackay F, Pers JO,. B-cell tolerance breakdown in Sjögren's syndrome: focus on BAFF. Autoimmun Rev 2010; 9: 604-8.
3. Mariette X, Gottenberg JE,. Pathogenesis of Sjögren's syndrome and therapeutic consequences. Curr Opin Rheumatol 2010; 22: 471-7.
4. Kassan SS, Thomas TL, Moutsopoulos HM, Hoover R, Kimberly RP, Budman DR, et al. Increased risk of lymphoma in sicca syndrome. Ann Intern Med 1978; 89: 888-92.
5. Baimpa E, Dahabreh IJ, Voulgarelis M, Moutsopoulos HM,. Hematologic manifestations and predictors of lymphoma development in primary Sjögren syndrome: clinical and pathophysiologic aspects. Medicine (Baltimore) 2009; 88: 284-93.
6. Talal N, Sokoloff L, Barth WF,. Extrasalivary lymphoid abnormalities in Sjögren's syndrome (reticulum cell sarcoma, "pseudolymphoma," macroglobulinemia). Am J Med 1967; 43: 50-65.
7. Tzioufas AG, Boumba DS, Skopouli FN, Moutsopoulos HM,. Mixed monoclonal cryoglobulinemia and monoclonal rheumatoid factor cross-reactive idiotypes as predictive factors for the development of lymphoma in primary Sjögren's syndrome. Arthritis Rheum 1996; 39: 767-72.
8. Theander E, Henriksson G, Ljungberg O, Mandl T, Manthorpe R, Jacobsson LT,. Lymphoma and other malignancies in primary Sjögren's syndrome: a cohort study on cancer incidence and lymphoma predictors. Ann Rheum Dis 2006; 65: 796-803.
9. Skopouli FN, Dafni U, Ioannidis JP, Moutsopoulos HM,. Clinical evolution, and morbidity and mortality of primary Sjögren's syndrome. Semin Arthritis Rheum 2000; 29: 296-304.
10. Mariette X,. Lymphomas complicating Sjögren's syndrome and hepatitis C virus infection may share a common pathogenesis: chronic stimulation of rheumatoid factor B cells. Ann Rheum Dis 2001; 60: 1007-10.
11. Bahler DW, Miklos JA, Swerdlow SH,. Ongoing Ig gene hypermutation in salivary gland mucosa-associated lymphoid tissue-type lymphomas. Blood 1997; 89: 3335-44.
12. H genes show frequent use of V1-69 with distinctive CDR3 features. Blood 2000; 95: 3878-84.
13. Martin T, Weber JC, Levallois H, Labouret N, Soley A, Koenig S, et al. Salivary gland lymphomas in patients with Sjögren's syndrome may frequently develop from rheumatoid factor B cells. Arthritis Rheum 2000; 43: 908-16.
14. - human naive B cells contain mostly autoreactive unresponsive clones. Blood 2010; 115: 5026-36.
15. low B-cell subset. Blood 2011; 117: 5425-37.
16. -/low marginal zone-like B cell clones in hepatitis C virus infection-related autoimmunity. J Immunol 2011; 187: 6550-63.
17. Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, et al, and the European Study Group on Classification Criteria for Sjögren's Syndrome. Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002; 61: 554-8.
18. Harris NL, Jaffe ES, Diebold J, Flandrin G, Muller-Hermelink HK, Vardiman J, et al. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997. J Clin Oncol 1999; 17: 3835-49.
19. Wardemann H, Yurasov S, Schaefer A, Young JW, Meffre E, Nussenzweig MC,. Predominant autoantibody production by early human B cell precursors. Science 2003; 301: 1374-7.
20. Samuels J, Ng YS, Coupillaud C, Paget D, Meffre E,. Impaired early B cell tolerance in patients with rheumatoid arthritis. J Exp Med 2005; 201: 1659-67.
21. Lopez F, Textoris J, Bergon A, Didier G, Remy E, Granjeaud S, et al. TranscriptomeBrowser: a powerful and flexible toolbox to explore productively the transcriptional landscape of the Gene Expression Omnibus database. PLoS One 2008; 3: e4001.
22. Meffre E, Casellas R, Nussenzweig MC,. Antibody regulation of B cell development. Nat Immunol 2000; 1: 379-85.
23. Tedder TF, Tuscano J, Sato S, Kehrl JH,. CD22, a B lymphocyte-specific adhesion molecule that regulates antigen receptor signaling. Annu Rev Immunol 1997; 15: 481-504.
24. low B cells in common variable immunodeficiency resemble tissue homing, innate-like B cells. Proc Natl Acad Sci U S A 2009; 106: 13451-6.
25. low B cell population in the peripheral blood of patients with SLE. Clin Immunol 2004; 113: 161-71.
26. Hartley SB, Cooke MP, Fulcher DA, Harris AW, Cory S, Basten A, et al. Elimination of self-reactive B lymphocytes proceeds in two stages: arrested development and cell death. Cell 1993; 72: 325-35.
27. Mandik L, Katsumata M, Erikson J,. Effects of altered Bcl-2 expression on B lymphocyte selection. Ann N Y Acad Sci 1997; 815: 40-54.
28. Lyubchenko T, Dal Porto JM, Holers VM, Cambier JC,. Complement (C3d)-linked antigens break B cell anergy. J Immunol 2007; 179: 2695-9.
29. Mandik-Nayak L, Bui A, Noorchashm H, Eaton A, Erikson J,. Regulation of anti-double-stranded DNA B cells in nonautoimmune mice: localization to the T-B interface of the splenic follicle. J Exp Med 1997; 186: 1257-67.
30. Kochi Y, Yamada R, Suzuki A, Harley JB, Shirasawa S, Sawada T, et al. A functional variant in FCRL3, encoding Fc receptor-like 3, is associated with rheumatoid arthritis and several autoimmunities. Nat Genet 2005; 37: 478-85.
31. Li DH, Winslow MM, Cao TM, Chen AH, Davis CR, Mellins ED, et al. Modulation of peripheral B cell tolerance by CD72 in a murine model. Arthritis Rheum 2008; 58: 3192-204.
32. Fujimoto M, Sato S,. B cell signaling and autoimmune diseases: CD19/CD22 loop as a B cell signaling device to regulate the balance of autoimmunity. J Dermatol Sci 2007; 46: 1-9.
33. Li DH, Tung JW, Tarner IH, Snow AL, Yukinari T, Ngernmaneepothong R, et al. CD72 down-modulates BCR-induced signal transduction and diminishes survival in primary mature B lymphocytes. J Immunol 2006; 176: 5321-8.
34. Paolino M, Thien CB, Gruber T, Hinterleitner R, Baier G, Langdon WY, et al. Essential role of E3 ubiquitin ligase activity in Cbl-b-regulated T cell functions. J Immunol 2011; 186: 2138-47.
35. Cambier JC, Gauld SB, Merrell KT, Vilen BJ,. B-cell anergy: from transgenic models to naturally occurring anergic B cells? Nat Rev Immunol 2007; 7: 633-43.
36. Leadbetter EA, Rifkin IR, Hohlbaum AM, Beaudette BC, Shlomchik MJ, Marshak-Rothstein A,. Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors. Nature 2002; 416: 603-7.
37. Saadoun D, Suarez F, Lefrere F, Valensi F, Mariette X, Aouba A, et al. Splenic lymphoma with villous lymphocytes, associated with type II cryoglobulinemia and HCV infection: a new entity? Blood 2005; 105: 74-6.
38. Mariette X, Gozlan J, Clerc D, Bisson M, Morinet F,. Detection of Epstein-Barr virus DNA by in situ hybridization and polymerase chain reaction in salivary gland biopsy specimens from patients with Sjögren's syndrome. Am J Med 1991; 90: 286-94.
39. Inoue H, Tsubota K, Ono M, Kizu Y, Mizuno F, Takada K, et al. Possible involvement of EBV-mediated α-fodrin cleavage for organ-specific autoantigen in Sjögren's syndrome. J Immunol 2001; 166: 5801-9.
40. Iwakiri D, Zhou L, Samanta M, Matsumoto M, Ebihara T, Seya T, et al. Epstein-Barr virus (EBV)-encoded small RNA is released from EBV-infected cells and activates signaling from Toll-like receptor 3. J Exp Med 2009; 206: 2091-9.